Multiple mechanisms underlying the anticancer action of nanocrystalline fullerene

Using the rat glioma cell line C6 and the human glioma cell line U251, we demonstrate the multiple mechanisms underlying the in vitro anticancer effects of the C 60 fullerene water suspension (nano-C 60 or nC 60) produced by solvent exchange method. Nano-C 60 in a dose-dependent manner reduced the t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmacology 2007-07, Vol.568 (1), p.89-98
Hauptverfasser: Harhaji, Ljubica, Isakovic, Aleksandra, Raicevic, Nevena, Markovic, Zoran, Todorovic-Markovic, Biljana, Nikolic, Nadezda, Vranjes-Djuric, Sanja, Markovic, Ivanka, Trajkovic, Vladimir
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Using the rat glioma cell line C6 and the human glioma cell line U251, we demonstrate the multiple mechanisms underlying the in vitro anticancer effects of the C 60 fullerene water suspension (nano-C 60 or nC 60) produced by solvent exchange method. Nano-C 60 in a dose-dependent manner reduced the tumor cell numbers after 24 h of incubation. The observed antiglioma action of nC 60 at high concentration (1 μg/ml) was due to a reactive oxygen species-mediated necrotic cell damage that was partly dependent on oxidative stress-induced activation of extracellular signal-regulated kinase (ERK). On the other hand, low-dose nC 60 (0.25 μg/ml) did not induce either necrotic or apoptotic cell death, but caused oxidative stress/ERK-independent cell cycle block in G 2/M phase and subsequent inhibition of tumor cell proliferation. Treatment with either high-dose or low-dose nC 60 caused the appearance of acidified intracytoplasmic vesicles indicative of autophagy, but only the antiglioma effect of low-dose nC 60 was significantly attenuated by inhibiting autophagy with bafilomycin A1. Importantly, primary rat astrocytes were less sensitive than their transformed counterparts to a cytostatic action of low-dose nC 60. These data provide grounds for further development of nC 60 as an anticancer agent.
ISSN:0014-2999
1879-0712
DOI:10.1016/j.ejphar.2007.04.041